FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2171216272> ?p ?o ?g. }

• W2171216272 endingPage "14" @default.
• W2171216272 startingPage "402" @default.
• W2171216272 abstract "Tumors are sensitive to iron (Fe) chelation therapy with the clinically used chelator desferrioxamine (DFO). Recently, the potent inhibitor of ribonucleotide reductase, Triapine, has entered clinical trials as an anticancer agent. This compound is a potential Fe chelator, but despite this, no investigations have examined its effect on cellular Fe metabolism. This is essential for understanding its mechanism of action and clinical effects.We compared the effect of Triapine with DFO, and also with the novel Fe chelator, 311, which shows marked antiproliferative activity. This latter ligand was relevant to compare, because it is tridentate like Triapine and shares structural similarity. We assessed the effects of chelators on proliferation, Fe uptake, Fe efflux, the expression of cell cycle control molecules, and iron-regulatory protein-RNA-binding activity. Redox activity was determined by ascorbate oxidation, benzoate hydroxylation, plasmid DNA degradation, and the precipitation of cellular DNA. These studies have been performed using several neuroepithelioma and neuroblastoma cell lines and a variety of normal cell types including fibroblasts, umbilical vein endothelial cells, skeletal muscle cells, monocyte-derived macrophages, and bone marrow stem cells.Triapine was twice as effective as DFO at mobilizing (59)Fe from prelabeled cells but was much less efficient than 311. In terms of preventing (59)Fe uptake from Tf, Triapine and DFO had similar activity, having far less efficacy than 311. All three of the chelators showed greater activity against the proliferation of neoplastic than of normal cells, the effect of 311 and Triapine being similar and these two chelators being significantly (P < 0.0001) more active than DFO. Complexation of Triapine with Fe had no appreciable effect on its antiproliferative activity, whereas addition of Fe totally inhibited the effects of DFO and 311. Furthermore, the Triapine Fe complex was shown to be redox active.The cytotoxic mechanism of action of Triapine was different from that of DFO and 311, with the combined action of Fe chelation and free radical generation being involved." @default.
• W2171216272 created "2016-06-24" @default.
• W2171216272 creator A5033446002 @default.
• W2171216272 creator A5055735150 @default.
• W2171216272 creator A5061763563 @default.
• W2171216272 creator A5089917423 @default.
• W2171216272 date "2003-01-01" @default.
• W2171216272 modified "2023-09-23" @default.
• W2171216272 title "Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311." @default.
• W2171216272 cites W116663061 @default.
• W2171216272 cites W1502461041 @default.
• W2171216272 cites W1507513252 @default.
• W2171216272 cites W1508340483 @default.
• W2171216272 cites W1535189264 @default.
• W2171216272 cites W1535828429 @default.
• W2171216272 cites W1550693195 @default.
• W2171216272 cites W1564880933 @default.
• W2171216272 cites W1577909961 @default.
• W2171216272 cites W1688113587 @default.
• W2171216272 cites W169275994 @default.
• W2171216272 cites W1809574325 @default.
• W2171216272 cites W1822715048 @default.
• W2171216272 cites W1871616831 @default.
• W2171216272 cites W1894026278 @default.
• W2171216272 cites W1900681258 @default.
• W2171216272 cites W1966431174 @default.
• W2171216272 cites W1970929549 @default.
• W2171216272 cites W1971437863 @default.
• W2171216272 cites W1973885754 @default.
• W2171216272 cites W1996920684 @default.
• W2171216272 cites W2006277511 @default.
• W2171216272 cites W2011862846 @default.
• W2171216272 cites W2012677679 @default.
• W2171216272 cites W2015113703 @default.
• W2171216272 cites W2017350478 @default.
• W2171216272 cites W2019227458 @default.
• W2171216272 cites W2035763080 @default.
• W2171216272 cites W2039510124 @default.
• W2171216272 cites W2040919827 @default.
• W2171216272 cites W2042216581 @default.
• W2171216272 cites W2045024336 @default.
• W2171216272 cites W2051983330 @default.
• W2171216272 cites W2058409066 @default.
• W2171216272 cites W2059308081 @default.
• W2171216272 cites W2059502417 @default.
• W2171216272 cites W2060026323 @default.
• W2171216272 cites W2063576996 @default.
• W2171216272 cites W2065604071 @default.
• W2171216272 cites W2067900214 @default.
• W2171216272 cites W2071353722 @default.
• W2171216272 cites W2073915702 @default.
• W2171216272 cites W2078010998 @default.
• W2171216272 cites W2081330846 @default.
• W2171216272 cites W2085866164 @default.
• W2171216272 cites W2094335678 @default.
• W2171216272 cites W2096825118 @default.
• W2171216272 cites W2104434601 @default.
• W2171216272 cites W2118561871 @default.
• W2171216272 cites W2118989195 @default.
• W2171216272 cites W2119272726 @default.
• W2171216272 cites W2138094292 @default.
• W2171216272 cites W2146449631 @default.
• W2171216272 cites W2159401034 @default.
• W2171216272 cites W2159574733 @default.
• W2171216272 cites W2160225986 @default.
• W2171216272 cites W2164601045 @default.
• W2171216272 cites W2170247657 @default.
• W2171216272 cites W2178778111 @default.
• W2171216272 cites W2223245761 @default.
• W2171216272 cites W2339869834 @default.
• W2171216272 cites W2343696406 @default.
• W2171216272 cites W2401833113 @default.
• W2171216272 cites W2465921122 @default.
• W2171216272 cites W34816746 @default.
• W2171216272 cites W575850908 @default.
• W2171216272 cites W84519370 @default.
• W2171216272 cites W954280178 @default.
• W2171216272 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12538494" @default.
• W2171216272 hasPublicationYear "2003" @default.
• W2171216272 type Work @default.
• W2171216272 sameAs 2171216272 @default.
• W2171216272 citedByCount "47" @default.
• W2171216272 countsByYear W21712162722012 @default.
• W2171216272 countsByYear W21712162722013 @default.
• W2171216272 countsByYear W21712162722014 @default.
• W2171216272 countsByYear W21712162722015 @default.
• W2171216272 countsByYear W21712162722016 @default.
• W2171216272 countsByYear W21712162722017 @default.
• W2171216272 countsByYear W21712162722018 @default.
• W2171216272 countsByYear W21712162722019 @default.
• W2171216272 countsByYear W21712162722020 @default.
• W2171216272 countsByYear W21712162722022 @default.
• W2171216272 countsByYear W21712162722023 @default.
• W2171216272 crossrefType "journal-article" @default.
• W2171216272 hasAuthorship W2171216272A5033446002 @default.
• W2171216272 hasAuthorship W2171216272A5055735150 @default.
• W2171216272 hasAuthorship W2171216272A5061763563 @default.
• W2171216272 hasAuthorship W2171216272A5089917423 @default.

• next